Connecticut
How Enright v. Eli Lilly & Co. applies in Connecticut: state-specific rules, key cases, and bar exam notes for Other.
Connecticut law reflects a strong emphasis on the doctrine of informed consent in medical malpractice cases, similar to the principles established in Enright v. Eli Lilly & Co. The court in Connecticut considers the patient's right to understand the risks and benefits involved in treatment, focusing on whether adequate disclosure was made.
In Connecticut, a physician's duty encompasses the obligation to provide sufficient information to a patient to allow for informed consent, which aligns with the principles of informed consent established in Enright v. Eli Lilly & Co.
The court held that a physician must disclose material risks associated with a proposed treatment for the consent to be considered valid.
The ruling emphasized the need for healthcare providers to inform patients adequately about potential complications related to procedures they undergo.
Affirmed that informed consent is crucial, and failure to provide necessary information could lead to liability for medical malpractice.
Connecticut's approach to informed consent closely parallels federal standards, in which patients must be made aware of risks to make autonomous decisions regarding their care. However, Connecticut statutes and case law provide more explicit parameters on what constitutes adequate disclosure and informed consent compared to some federal interpretations.
Understanding the principles established in Enright v. Eli Lilly & Co. is crucial for Connecticut bar exam candidates, particularly in the context of medical malpractice and tort law questions.